IL6 and adult-onset Still disease: The treatment of effusions in AOSD involves managing the underlying inflammatory process with medications such as corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDs), and biologics targeting specific cytokines (e.g., interleukin-1 or interleukin-6 antagonists) [2].